Virtual Research & Development Day to provide an update on the Company’s clinical program, Farudodstat, will be held on March 16 at 10 am. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ASLN:
- ASLAN Pharmaceuticals Announces Acceptance of Two Abstracts for Poster Presentation at the 1st International Societies for Investigative Dermatology Meeting
- Aslan Pharmaceuticals announces plan to implement ADS ratio change
- ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change
- Aslan Pharmaceuticals to host virtual research day on AA
- Aslan Pharmaceuticals to advance farudodstat into Phase 2 clinical testing